Local Institution - 0140

London, London, City of NW1 2PG

2 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Systemic Sclerosis

Studies at this site

• Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) — Recruiting now
• A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis — Starting soon